Article Versions Notes

Yadavalli CS, Upparahalli Venkateshaiah S, Verma AK, Kathera C, Duncan PS, Vaezi M, Paul RJ, Mishra A. Vasoactive Intestinal Peptide Receptor, CRTH2, Antagonist Treatment Improves Eosinophil and Mast Cell-Mediated Esophageal Remodeling and Motility Dysfunction in Eosinophilic Esophagitis. Cells. 2024; 13(4):295. https://doi.org/10.3390/cells13040295

Yadavalli, Chandra Sekhar, Sathisha Upparahalli Venkateshaiah, Alok K. Verma, Chandrasekhar Kathera, Pearce S. Duncan, Michael Vaezi, Richard J. Paul, and Anil Mishra. 2024. "Vasoactive Intestinal Peptide Receptor, CRTH2, Antagonist Treatment Improves Eosinophil and Mast Cell-Mediated Esophageal Remodeling and Motility Dysfunction in Eosinophilic Esophagitis" Cells 13, no. 4: 295. https://doi.org/10.3390/cells13040295

Yadavalli, C. S., Upparahalli Venkateshaiah, S., Verma, A. K., Kathera, C., Duncan, P. S., Vaezi, M., Paul, R. J., & Mishra, A. (2024). Vasoactive Intestinal Peptide Receptor, CRTH2, Antagonist Treatment Improves Eosinophil and Mast Cell-Mediated Esophageal Remodeling and Motility Dysfunction in Eosinophilic Esophagitis. Cells, 13(4), 295. https://doi.org/10.3390/cells13040295